Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada-Reference-Cited by-同舟云学术

Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada

Published:2015-09-22 Issue:1 Volume:55 Page:16-24
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Huang Steven J. T.¹²,Gillan Tanya L.²,Gerrie Alina S.¹,Hrynchak Monica³,Karsan Aly⁴,Ramadan Khaled⁵,Smith Adam C.⁶,Toze Cynthia L.¹,Bruyere Helene²

Affiliation:

1. Leukemia/BMT Program of BC, Vancouver General Hospital and British Columbia Cancer Agency; University of British Columbia; Vancouver BC Canada

2. Pathology and Laboratory Medicine; Vancouver General Hospital University of British Columbia; Vancouver BC Canada

3. Department of Laboratory Medicine Molecular Cytogenetic Laboratory, Royal Columbian Hospital; University of British Columbia; New Westminster BC Canada

4. Pathology and Laboratory Medicine; British Columbia Cancer Agency; Vancouver BC Canada

5. Division of Hematology; St. Paul's Hospital University of British Columbia; Vancouver BC Canada

6. Instituto De Pesquisa Pelé Pequeno Príncipe, Curitiba, Brazil and the Dept. Of Pathology; University of British Columbia; Vancouver Canada

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gcc.22294/fullpdf

Reference30 articles.

1. British Columbia Cancer Agency http://www.bccancer.bc.ca/health-professionals/professional-resources/cancer-management-guidelines/lymphoma-chronic-leukemia-myeloma/chronic-leukemia 2015

2. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): A randomised controlled trial;Catovsky;Lancet,2007

3. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis;Cavazzini;Br J Haematol,2008

4. Chronic lymphocytic leukemia;Chiorazzi;N Engl J Med,2005

5. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis;Cuneo;Leukemia,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD4+ chronic lymphocytic leukemia in an 86‐year‐old male veteran: A case report;eJHaem;2024-06-21

2. Expert consensus on the management of chronic lymphocytic leukaemia in Asia;Clinical and Experimental Medicine;2023-02-16

3. CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia;Acta Haematologica;2023

4. Artificial intelligence models in chronic lymphocytic leukemia – recommendations toward state-of-the-art;Leukemia & Lymphoma;2021-10-06

5. Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?;Molecular Cytogenetics;2021-01-06